Bill Summary
SB 172 Florida Drug and Cosmetic Act (2020 Session)
Florida Drug and Cosmetic Act; Preempting the regulation of over-the-counter proprietary drugs or cosmetics to the state, etc. Effective Date: 7/1/2020
08/22/19
SENATE
Filed
09/19/19
SENATE
Referred to Community Affairs; Innovation, Industry, and Technology; Rules
10/07/19
SENATE
On Committee agenda - Community Affairs, 10/14/19, 4:30 pm, 301 S
10/14/19
SENATE
Favorable by Community Affairs; 3 Yeas, 1 Nay
10/15/19
SENATE
Now in Innovation, Industry, and Technology
10/28/19
SENATE
On Committee agenda - Innovation, Industry, and Technology, 11/04/19, 1:30 pm, 110 S
11/04/19
SENATE
Favorable by Innovation, Industry, and Technology; 8 Yeas, 2 Nays
11/04/19
SENATE
Now in Rules
01/10/20
SENATE
On Committee agenda - Rules, 01/15/20, 8:30 am, 110 S
01/15/20
SENATE
Favorable by Rules; 12 Yeas, 4 Nays
01/15/20
SENATE
Placed on Calendar, on 2nd reading
01/16/20
SENATE
Placed on Special Order Calendar, 01/22/20
01/22/20
SENATE
Read Second Time; Placed on Third Reading, 01/29/20
01/29/20
SENATE
Read Third Time; Passed (Vote: 25 Yeas / 14 Nays)
02/04/20
HOUSE
In Messages
03/06/20
HOUSE
Received; Referred to Calendar
03/06/20
HOUSE
Placed on Special Order Calendar, 03/09/20
03/09/20
HOUSE
Read Second Time; Placed on Third Reading, 03/10/20
03/10/20
HOUSE
Read Third Time; Passed (Vote: 68 Yeas / 47 Nays)
03/10/20
SENATE
Ordered enrolled
03/10/20
SENATE
Enrolled Text (ER) Filed
06/16/20
______
Signed by Officers and presented to Governor (Governor must act on this bill by 06/30/20)
06/29/20
______
Approved by Governor; Chapter No. 2020-118
499.002
Research & Reports
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.
No reports related to this bill.
Upcoming Events
Florida's most comprehensive legislative calendar.
Learn more.
No events are scheduled at this time.
Press Releases
Related Press Announcements. Learn more.
No press releases related to this bill.
Features above are available to LobbyTools subscribers.
Request a free demo or call (850) 915-0100 ext. 2 to learn more.